Coalition for Epidemic Preparedness Innovations ^Investors

The Coalition for Epidemic Preparedness Innovations (CEPI) is a non-profit organization based in Washington, District of Columbia, United States. Founded in 2017, CEPI focuses on accelerating the development of vaccines against emerging infectious diseases. Operating primarily in the Washington DC Metro Area and the Southern US, CEPI has invested in various pharmaceutical and biomed companies to combat epidemics. One notable investment is NEC OncoImmunity AS, a company specializing in artificial intelligence-driven vaccine design for cancer immunotherapy. CEPI's presence in these regions highlights its commitment to advancing biotech, pharma, and Biomed sectors in the fight against epidemics.